Here’s what you should know:
1. Plenvu additionally focuses on preparing the ascending colon.
2. If approved, Plenvu will tout the lowest total volume of solution for a bowel cleanser.
3. Salix expects an FDA decision in the first quarter of fiscal year 2018.
4. Salix is a subsidiary of Valeant Pharmaceuticals.
More articles on gastroenterology:
Synthetic Biologics receives Patent office allowance for active agent in IBS-C treatment — 3 key notes
GI center to know: Gastroenterology of the Rockies
Exact Sciences partners with pro-golfer & more — 6 GI company key notes
